In this segment from Tuesday's Investor Beat, Motley Fool analyst Morgan Housel discusses the iShares NASDAQ Biotechnology Index (NASDAQ:IBB), and why he sees many tell-tale red flags that the biotech space is in a bubble right now. Morgan gives his insight on what these warning signs are, and whether or not the bubble could be near collapse.
Full-time host of the Motley Fool Money radio show, MarketFoolery podcast, and other things. Part-time connoisseur of movies, basketball & fine bourbon.
- Mar 26, 2014 at 9:30AM
- Health Care